Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis.
Focal Injection of Ethidium Bromide as a Simple Model to Study Cognitive Deficit and Its Improvement.
Gray matter-related proteins are associated with childhood-onset multiple sclerosis.
Kinematic gait parameters are highly sensitive measures of motor deficits and spinal cord injury in mice subjected to experimental autoimmune encephalomyelitis.
Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.
Statistical estimation of white matter microstructure from conventional MRI.
Erratum: Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis.
Activation of Wnt signaling promotes hippocampal neurogenesis in experimental autoimmune encephalomyelitis.
Autonomic function and brain volume.
Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA.
Early hematopoiesis in multiple sclerosis patients.
Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients.
Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation.
[Exogenous evoked potentials in adolesccents with muftiple sclerosis].
First use of alemtuzumab in balo concentric sclerosis: a case report.
In vivo amyloid aggregation kinetics tracked by time-lapse confocal microscopy in real-time.
Selective and compartmentalized myelin expression of HspB5.
Patterns of white matter damage are non-random and associated with cognitive function in secondary progressive multiple sclerosis.
Alemtuzumab-induced elimination of HIV-1-infected immune cells.
ST8SIA2 promotes oligodendrocyte differentiation and the integrity of myelin and axons.
Interferon β associated nephropathy in a Multiple Sclerosis patient: A case and review.
Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin.
Discovery of a novel JAK3-selective inhibitor: Functional differentiation of JAK3-selective inhibition over pan-JAK or JAK1-selective inhibition.
Clinical Reasoning: Bacterial meningitis causing a neuromyelitis optica flare.
HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation.
Pages
« first
‹ previous
…
762
763
764
765
766
767
768
769
770
…
next ›
last »